28th September 2026 Tomorrow, on World Heart Day, the Pumping Marvellous Foundation and the Heart Failure Academy will launch Navigating the Heart Failure Journey in Primary Care: A Personalised Approach to Living Well at an invite-only event at the Leeds Armouries. Developed jointly for generalist multidisciplinary teams in primary care, the practical, evidence-based booklet brings the experience […]

Government explicitly backs AI-assisted echocardiography for earlier CVD diagnosis. Lord Taylor of Warwick received the Government’s answer on 22 September 2026 to his question about NHS adoption of AI for early detection of heart disease. Responding for DHSC, Baroness Merron confirmed that Government is exploring AI for earlier detection and diagnosis of CVD and specifically named AI-assisted […]

Juliet Campbell (Labour, Broxtowe) has now moved beyond speaking about heart failure in debate and has begun using written parliamentary questions to probe specific changes to the diagnostic pathway. On 18 September 2026, Health Minister James Frith answered two questions Campbell had tabled on 8 September 2026. Juliet asked firstly whether DHSC would pilot NT-proBNP point-of-care testing in community pharmacies for people […]

Alicia Kearns (Conservative, Rutland and Stamford) has now received the Government’s response to her parliamentary intervention on reform of vascular services, answered by Health Minister James Frith on 15 September 2026. This matters beyond vascular disease because the response gives a useful indication of how DHSC is beginning to talk about implementation of the new CVD Modern Service Framework. […]

A significant new heart failure development has emerged in Parliament.  It is well aligned with patient priorities. We have also been working with Juliet’s team along with sending a detailed letter to James Frith. Juliet Campbell MP (Labour, Broxtowe) used a Westminster Hall debate on 10 September 2026 to make a detailed intervention specifically on heart failure. […]

Pumping Marvellous Foundation Heart Failure Brief — 14th September 2026   Ziltivekimab heart-failure studies stopped early Novo Nordisk confirmed on 7th September 2026 that it had terminated two heart-failure studies of Ziltivekimab, an experimental monoclonal antibody targeting interleukin-6 inflammation. The decision followed the unsuccessful phase III ZEUS study in more than 6,300 people with atherosclerotic […]

Pumping Marvellous Foundation Heart Failure Brief — 7th September 2026 The major development in recent weeks is the publication of the full 2026 European Society of Cardiology (ESC) heart failure guidelines, accompanied by the ESC’s first dedicated cardiac rehabilitation guidelines. Together, they strengthen our arguments around prevention, patient participation, rehabilitation access and flexible community delivery. […]